{
    "organizations": [],
    "uuid": "6b7744417e3cdb6d20e7aa94e13e25de1670662a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ri-affirms-mitsubishi-tanabe-pharm/brief-ri-affirms-mitsubishi-tanabe-pharmas-rating-at-a-and-announces-stable-outlook-ri-idUSL3N1RV2Y5",
    "ord_in_thread": 0,
    "title": "BRIEF- R&I affirms Mitsubishi Tanabe Pharma's rating at A+ and announces stable outlook-R&I",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18(Reuters) - Mitsubishi Tanabe Pharma Corp\n* Rating and Investment Information, Inc. (R&I) affirmed the company’s rating at “A+” -R&I\n* Says rating outlook stable -R&I\nSource text in Japanese: goo.gl/RkxEsL\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-18T14:35:00.000+03:00",
    "crawled": "2018-04-19T14:41:09.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "mitsubishi",
        "tanabe",
        "pharma",
        "corp",
        "rating",
        "investment",
        "information",
        "r",
        "affirmed",
        "company",
        "rating",
        "say",
        "rating",
        "outlook",
        "stable",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}